Clinical Trial Details
EORTC-55923
Back to Clinical Trials Database
Phase II study of Cisplatin, Doxorubicin, and Ifosfamide in carcinosarcoma (malignant mixed mesodermal tumors) of the female genital tract
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 06-Sep-1993 Date Step1 close: 21-Apr-1998 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 25 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |